Strata Skin Sciences, Inc.
SSKN
$2.20
-$0.0636-2.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.81M | 9.58M | 8.80M | 8.44M | 6.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.81M | 9.58M | 8.80M | 8.44M | 6.75M |
| Cost of Revenue | 3.17M | 3.82M | 3.49M | 3.50M | 3.67M |
| Gross Profit | 3.65M | 5.76M | 5.31M | 4.94M | 3.08M |
| SG&A Expenses | 5.57M | 5.92M | 6.72M | 5.22M | 5.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.83M | 9.94M | 10.45M | 8.92M | 9.64M |
| Operating Income | -2.02M | -366.00K | -1.65M | -486.00K | -2.89M |
| Income Before Tax | -2.43M | -4.67M | -2.12M | -99.00K | -3.37M |
| Income Tax Expenses | -- | -170.00K | -- | -- | -- |
| Earnings from Continuing Operations | -2.43M | -4.50M | -2.12M | -99.00K | -3.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.43M | -4.50M | -2.12M | -99.00K | -3.37M |
| EBIT | -2.02M | -366.00K | -1.65M | -486.00K | -2.89M |
| EBITDA | -795.00K | 864.00K | -414.00K | 764.00K | -1.64M |
| EPS Basic | -0.58 | -1.08 | -0.53 | -0.03 | -0.96 |
| Normalized Basic EPS | -0.36 | -0.12 | -0.33 | -0.17 | -0.60 |
| EPS Diluted | -0.58 | -1.08 | -0.53 | -0.03 | -0.96 |
| Normalized Diluted EPS | -0.36 | -0.12 | -0.33 | -0.17 | -0.60 |
| Average Basic Shares Outstanding | 4.17M | 4.17M | 4.04M | 3.51M | 3.51M |
| Average Diluted Shares Outstanding | 4.17M | 4.17M | 4.04M | 3.51M | 3.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |